
Orchard Therapeutics
Dedicated to transforming the lives of patients with severe and other genetic diseases through innovative gene therapy.
Stem cell technology β’ Gene therapy β’ Orphan diseases β’ Paediatric diseases

201 - 500
π° $150M Post-IPO Equity on 2021-02